Explore
Validate
LearnABIN152139
antibody from antibodies-online
Targeting: CXCR4
CD184, D2S201E, fusin, HM89, HSY3RR, LESTR, NPY3R, NPYR, NPYY3R
Western blot
ImmunocytochemistryAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Immunocytochemistry [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN152139 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Chemokine (C-X-C Motif) Receptor 4 (CXCR4) (N-Term) antibody
- Antibody type
- Polyclonal
- Description
- Immunogen affinity purified
- Reactivity
- Human, Rat
- Host
- Goat
- Epitope
- N-Term
- Vial size
- 0.1 mg
- Storage
- Store at -20°C. Avoid freeze-thaw cycles.
- Handling
- Avoid freeze-thaw cycles
Submitted references Chemokine receptor CXCR4 regulates CaMKII/CREB pathway in spinal neurons that underlies cancer-induced bone pain.
Clinical significance of CXC chemokine receptor-4 and c-Met in childhood rhabdomyosarcoma.
Effect of chemokine receptors CXCR4 and CCR7 on the metastatic behavior of human colorectal cancer.
The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry.
Cloning of a human seven-transmembrane domain receptor, LESTR, that is highly expressed in leukocytes.
Hu XM, Zhang H, Xu H, Zhang HL, Chen LP, Cui WQ, Yang W, Shen W
Scientific reports 2017 Jun 21;7(1):4005
Scientific reports 2017 Jun 21;7(1):4005
Clinical significance of CXC chemokine receptor-4 and c-Met in childhood rhabdomyosarcoma.
Diomedi-Camassei F, McDowell HP, De Ioris MA, Uccini S, Altavista P, Raschellà G, Vitali R, Mannarino O, De Sio L, Cozzi DA, Donfrancesco A, Inserra A, Callea F, Dominici C
Clinical cancer research : an official journal of the American Association for Cancer Research 2008 Jul 1;14(13):4119-27
Clinical cancer research : an official journal of the American Association for Cancer Research 2008 Jul 1;14(13):4119-27
Effect of chemokine receptors CXCR4 and CCR7 on the metastatic behavior of human colorectal cancer.
Schimanski CC, Schwald S, Simiantonaki N, Jayasinghe C, Gönner U, Wilsberg V, Junginger T, Berger MR, Galle PR, Moehler M
Clinical cancer research : an official journal of the American Association for Cancer Research 2005 Mar 1;11(5):1743-50
Clinical cancer research : an official journal of the American Association for Cancer Research 2005 Mar 1;11(5):1743-50
The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry.
Bleul CC, Farzan M, Choe H, Parolin C, Clark-Lewis I, Sodroski J, Springer TA
Nature 1996 Aug 29;382(6594):829-33
Nature 1996 Aug 29;382(6594):829-33
Cloning of a human seven-transmembrane domain receptor, LESTR, that is highly expressed in leukocytes.
Loetscher M, Geiser T, O'Reilly T, Zwahlen R, Baggiolini M, Moser B
The Journal of biological chemistry 1994 Jan 7;269(1):232-7
The Journal of biological chemistry 1994 Jan 7;269(1):232-7
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- Anti-CXCR4 Inhibition of SDF-Induced Activation DU145
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
